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The etiopathogenesis of amyotrophic lat-
eral sclerosis (ALS) remains contentious, 
but new findings related to mutations of 
the Cu, Zn-superoxide dismutase (SOD1) 
gene continue to provide crucial insights. 
Using a conformation-specific antibody 
that detects misfolded SOD1 (C4F6), Bosco 
et al. (2010) recently reported that oxidized 
wild-type SOD1 and mutant SOD1 share a 
conformational epitope that is not present 
in normal wild-type SOD1, but present 
in a subset of sporadic ALS (SALS) cases. 
Recombinant, oxidized wild-type SOD1 
and wild-type SOD1 immunopurified 
from SALS tissues inhibited axonal trans-
port in a manner similar to that of familial 
ALS (FALS)-linked mutant SOD1 (Bosco 
et al., 2010), indicating that wild-type SOD1 
might develop a pathogenic modification 
even in SALS cases. The authors noted that 
a specific SOD1 residue, Cys111, was critical 
for the pathological C4F6 epitope (Bosco 
et al., 2010). This report carries added sig-
nificance because it overlaps with recent 
observations about copper interactions in 
ALS pathogenesis that implicate the same 
residue in oxidized SOD1.
Since SOD1 is a major Cu-binding pro-
tein, and since Cu can be harmfully pro-
oxidant, considerable research has explored 
whether aberrant Cu biochemistry could 
underlie FALS pathogenesis. Indeed, phar-
macological and genetic interventions that 
lower intracellular Cu partly rescue the 
FALS phenotype in mutant SOD1 trans-
genic mice (Hottinger et al., 1997; Nagano 
et al., 1999, 2003; Kiaei et al., 2004; Tokuda 
et al., 2008). Conversely, overexpression of 
the Cu-chaperone of SOD1 (CCS), which 
presents Cu to SOD1, worsens the FALS 
phenotype in double CCS/mutant SOD1 
transgenic mice (Son et al., 2007). On the 
other hand, the FALS phenotype was not 
affected by genetic deletion of CCS (CCS 
knockout mice crossed with mutant SOD1 
mice; Subramaniam et al., 2002). Also, 
active site copper was effectively eliminated 
from the pathogenic reaction via amino acid 
substitutions that disrupt copper binding 
but do not eliminate toxicity, and patho-
genic mutant SOD1 mice express normally 
active and normally metallated dimeric 
SOD1 (Lelie et al., 2011).
The critical Cys111 of pathogenic SOD1 
described by Bosco et al. (2010) may rec-
oncile the evidence implicating Cu with 
the evidence supporting pathogenic SOD1 
instability, by supporting the possibility that 
ectopic binding of Cu outside the active 
site could contribute to pathogenesis (Liu 
et al., 2000). Immobilized Cu affinity chro-
matography resolves FALS-mutant SOD1 
into an abnormal high-affinity fraction, 
termed SOD1HAC (Watanabe et al., 2007). 
SOD1HAC was observed for all pathogenic 
SOD1 mutants whether expressed in yeast, 
mammalian cell culture, or transgenic 
mouse spinal cords (Watanabe et al., 2007). 
SOD1HAC could be generated from wild-type 
SOD1 by Cys111 oxidation with GSNO or 
hydrogen peroxide, which induced SOD1 
monomerization. Covalent cross-linking of 
mutant SOD1 prevented such monomeri-
zation (Kishigami et al., 2010), consistent 
with monomerization of SOD1 being nec-
essary for the formation of the adventitial 
high-affinity Cu-binding site on SOD1HAC. 
While the precise site is not clear, ectopic Cu 
binding to SOD1HAC gains redox-activity.
(Kishigami et al., 2010).
Mutant SOD1 is more susceptible to 
intramolecular disulfide reduction (Tiwari 
and Hayward, 2003). This renders the 
critical Cys111 vulnerable to modification 
by GSNO or peroxide that could induce 
monomerization and SOD1HAC formation, 
consistent with the hypothesis that SOD1 is 
dissociated into a potentially toxic SOD1HAC 
monomer when Cys111 is targeted by oxi-
dative stress products like GSNO or H
2
O
2
, 
an event of increased likelihood in SOD1 
mutants. Cys111 modification appears 
to disrupt the contact of the dimer inter-
face between subunits. The finding that 
C111S substitution decreased SOD1HAC in 
mutant SOD1 (Watanabe et al., 2007) sup-
ports this contention. A similar cysteine-
mediated conformational change has been 
reported for transthyretin, whose mutations 
cause familial amyloid polyneuropathy. 
Modification of a cysteine residue in tran-
sthyretin was shown to decrease tetramer 
stability, thereby generating monomer that 
subsequently formed amyloid (Zhang and 
Kelly, 2003, 2005). The findings of Bosco 
et al. (2010), who demonstrated that oxi-
dation of Cys111 mediated the pathogenic 
properties of SOD1, would be consistent 
with a similar pathogenic mechanism, 
and explain why dimeric forms of SOD1 
mutants may not be the primary toxic spe-
cies (Lelie et al., 2011).
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